BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18590537)

  • 1. Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors.
    Hashimoto Y; Skacel M; Adams JC
    BMC Cancer; 2008 Jun; 8():185. PubMed ID: 18590537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.
    Hashimoto Y; Skacel M; Lavery IC; Mukherjee AL; Casey G; Adams JC
    BMC Cancer; 2006 Oct; 6():241. PubMed ID: 17029629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.
    Kind S; Jaretzke A; Büscheck F; Möller K; Dum D; Höflmayer D; Hinsch A; Weidemann S; Fraune C; Möller-Koop C; Hube-Magg C; Simon R; Wilczak W; Lebok P; Witzel I; Müller V; Schmalfeldt B; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Krech T; Krech RH; von der Assen A; Bawahab AA; Burandt E
    Mol Carcinog; 2019 Dec; 58(12):2306-2315. PubMed ID: 31545001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters.
    Tsai WC; Chao YC; Sheu LF; Chang JL; Nieh S; Jin JS
    Dis Markers; 2007; 23(3):153-60. PubMed ID: 17473384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer.
    Wiksten JP; Lundin J; Nordling S; Lundin M; Kokkola A; von Boguslawski K; Haglund C
    Int J Cancer; 2001 Jan; 95(1):1-6. PubMed ID: 11241302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fascin expression in colorectal carcinomas.
    Ozerhan IH; Ersoz N; Onguru O; Ozturk M; Kurt B; Cetiner S
    Clinics (Sao Paulo); 2010 Feb; 65(2):157-64. PubMed ID: 20186299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomas.
    Lo PK; Lee JS; Chen H; Reisman D; Berger FG; Sukumar S
    Exp Mol Pathol; 2013 Feb; 94(1):262-9. PubMed ID: 23103611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer.
    Fujiya M; Watari J; Ashida T; Honda M; Tanabe H; Fujiki T; Saitoh Y; Kohgo Y
    Jpn J Cancer Res; 2001 Oct; 92(10):1074-81. PubMed ID: 11676858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of syndecan-1 and syndecan-2 expression in gallbladder squamous cell/adenosquamous carcinoma and adenocarcinoma].
    Tan XG; Yang ZL; Miao XY; Liu ZR; Li DQ; Zou Q; Li JH; Liang LF
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):28-34. PubMed ID: 29365414
    [No Abstract]   [Full Text] [Related]  

  • 10. Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer.
    Lundin M; Nordling S; Lundin J; Isola J; Wiksten JP; Haglund C
    Oncology; 2005; 68(4-6):306-13. PubMed ID: 16020957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer.
    Kusumoto T; Kodama J; Seki N; Nakamura K; Hongo A; Hiramatsu Y
    Oncol Rep; 2010 Apr; 23(4):917-25. PubMed ID: 20204274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with Stage II/III colorectal cancer.
    Roseweir AK; Kong CY; Park JH; Bennett L; Powell AGMT; Quinn J; van Wyk HC; Horgan PG; McMillan DC; Edwards J; Roxburgh CS
    Int J Cancer; 2019 Jan; 144(1):150-159. PubMed ID: 29992570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.
    Oh SY; Kim YB; Suh KW; Paek OJ; Moon HY
    J Surg Res; 2012 Jan; 172(1):102-8. PubMed ID: 20851411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fascin immunoreactivity for preoperatively predicting lymph node metastases in peripheral adenocarcinoma of the lung 3 cm or less in diameter.
    Choi PJ; Yang DK; Son CH; Lee KE; Lee JI; Roh MS
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):538-42. PubMed ID: 16870459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndecan-1 expression--a novel prognostic marker in pancreatic cancer.
    Juuti A; Nordling S; Lundin J; Louhimo J; Haglund C
    Oncology; 2005; 68(2-3):97-106. PubMed ID: 15886501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High fascin-1 expression in colorectal cancer identifies patients at high risk for early disease recurrence and associated mortality.
    Tampakis A; Tampaki EC; Nonni A; Kostakis ID; Posabella A; Kontzoglou K; von Flüe M; Felekouras E; Kouraklis G; Nikiteas N
    BMC Cancer; 2021 Feb; 21(1):153. PubMed ID: 33579217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of syndecan-1 mRNA and HPA-1 mRNA in colorectal cancer detected with real-time fluorescent quantitative polymerase chain reaction.
    Wang H; Si JL; Zhang XZ; Qi YQ; Niu ZY; Zhou CH
    Chin J Cancer; 2010 Mar; 29(3):288-93. PubMed ID: 20193112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
    Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
    Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Expression of Syndecan-1 in Cervical Cancers.
    Karászi K; Vigh R; Máthé M; Fullár A; Oláh L; Füle T; Papp Z; Kovalszky I
    Pathol Oncol Res; 2020 Oct; 26(4):2255-2264. PubMed ID: 32388727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas.
    St Hill CA; Farooqui M; Mitcheltree G; Gulbahce HE; Jessurun J; Cao Q; Walcheck B
    BMC Cancer; 2009 Mar; 9():79. PubMed ID: 19267921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.